Clin2
NCT07426705Possibly a fitNot yet recruiting

Probiotic supplement with rifaximin for irritable bowel syndrome

Small Intestinal Bacterial Overgrowth Syndrome (SIBO)IBS

Treatments studied

Part of Digestive system clinical trials.

This study tests whether adding a probiotic supplement to the antibiotic rifaximin improves treatment for people with irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO), a condition where too many bacteria grow in the small intestine. If you have IBS and SIBO, this combination might help reduce your symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with irritable bowel syndrome (IBS) based on the Rome IV criteria.
  • You have not taken antibiotics in the past 4 weeks.
  • You have not taken probiotics in the past 7 days.
  • You have no history of abdominal surgery.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07815548Not yet recruiting· Phase 4
Probiotic versus antibiotic for small intestinal bacterial overgrowth

This trial compares two treatments for SIBO, a condition that causes bloating and diarrhea due to too much bacteria in the small intestine. One treatment is a probiotic (a beneficial yeast) and the other is an antibiotic. The goal is to see which one works better.

Jinan, Shandong
NCT07768267Not yet recruiting· Phase 2
Herbal supplement for bacterial overgrowth in irritable bowel syndrome

This trial tests whether a herbal supplement called Biocidin REMOVE can help people with irritable bowel syndrome (IBS) who also have a condition called small intestinal bacterial overgrowth (SIBO), where too many bacteria grow in the small intestine. The study aims to see if the supplement can reduce symptoms and improve quality of life.

Baltimore, Maryland
NCT06298409Recruiting· Phase 1
Rifaximin for SIBO: Gut Bacteria Study

This study tests how Rifaximin (a medicine for SIBO) affects the bacteria and other substances in your gut. You'll swallow a small capsule that collects samples as it travels through your digestive system, so researchers can see how your gut changes during treatment.

Mountain View, California
NCT06772064Recruiting
Rifaximin for bloating caused by SIBO

This study tests whether the antibiotic rifaximin can relieve bloating in people with small intestinal bacterial overgrowth (SIBO). If you have chronic bloating and a positive SIBO breath test, this trial may be a good fit.

Jinan, Shandong
NCT07522255Not yet recruiting· Phase 3
Rifaximin for bloating in functional bowel disorders

This trial tests a medication called rifaximin (an antibiotic that works in the gut) to see if it reduces bloating in people with functional bowel disorders like IBS or chronic constipation. If you have stubborn bloating despite treatment, this could be a new option to help you feel better.

Bangkok Noi, Bangkok
NCT07872514Enrolling by invitation
Personalized probiotics for irritable bowel syndrome

This study tests whether a probiotic treatment designed specifically for you can help ease your irritable bowel syndrome (IBS) symptoms. If you make it into the study, you'll get a treatment plan tailored to your gut and your symptoms.

Hamilton, Ontario

Hear when a new Small Intestinal Bacterial Overgrowth Syndrome (SIBO) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.